Literature DB >> 22729570

AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.

Norman E Buroker1, Xue-Han Ning, Zhao-Nian Zhou, Kui Li, Wei-Jun Cen, Xiu-Feng Wu, Wei-Zhong Zhu, C Ronald Scott, Shi-Han Chen.   

Abstract

Mountain sickness (MS) occurs among humans visiting or inhabiting high altitude environments. We conducted genetic analyses of the AKT3, ANGPTL4, eNOS3 and VEGFA genes in lowland (Han) and highland (Tibetan) Chinese. Ten single nucleotide polymorphisms (SNPs) were evaluated in Han and Tibetan patients with acute (A) and chronic (C) MS. We compared 74 patients with AMS to 79 Han unaffected with MS, as well as 48 CMS patients to 31 unaffected Tibetans. The ten SNPs studied are AKT3 (rs4590656, rs2291409), ANGPTL4 (rs1044250), eNOS3 (rs1007311, rs1799983) and VEGFA (rs79469752, rs13207351, rs28357093, rs1570360, rs3025039). Direct sequencing was used to identify individual genotypes for these SNPs. Hemoglobin (Hb), hematocrit (Hct), and red blood cell count (RBC) were found to be significantly associated with the AKT3 SNP (rs4590656), Hb was found to be associated with the eNOS3 SNP (rs1007311), and RBC was found to be significantly associated with the VEGFA SNP (rs1570360) in Tibetan patients with CMS. CMS patients were found to diverge significantly for both eNOS3 SNPs as measured by genetic distance (0.042, 0.047) and for the VEGFA SNP (rs28357093) with a genetic distance of 0.078 compared to their Tibetan control group. Heart rate (HR) was found to be significantly associated with the eNOS3 SNP (rs1799983) and arterial oxygen saturation of hemoglobin (SaO2) was found to be significantly associated with the VEGFA SNPs (rs13207351, rs1570360) in Han patients with AMS. The Han and Tibetan control groups were found to diverge significantly for the ANGPTL4 SNP and VEGFA SNP (rs28357093), as measured by genetic distances of 0.049 and 0.073, respectively. Seven of the SNPs from non-coding regions are found in the transcriptional factor response elements and their possible role in gene regulation was evaluated with regard to MS. AMS and CMS were found to be significantly associated with the four genes compared to their Han and Tibetan control groups, respectively, indicating that these nucleotide alterations have a physiological effect for the development of high altitude sickness.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729570     DOI: 10.1007/s12185-012-1117-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  54 in total

1.  Proposal for scoring severity in chronic mountain sickness (CMS). Background and conclusions of the CMS Working Group.

Authors:  Fabiola León-Velarde; Rosann G McCullough; Robert E McCullough; John T Reeves
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

2.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles.

Authors:  Albin Sandelin; Wynand Alkema; Pär Engström; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

3.  LDA--a java-based linkage disequilibrium analyzer.

Authors:  Keyue Ding; Kaixin Zhou; Fuchu He; Yan Shen
Journal:  Bioinformatics       Date:  2003-11-01       Impact factor: 6.937

Review 4.  Acute mountain sickness: controversies and advances.

Authors:  Peter Bartsch; Damian M Bailey; Marc M Berger; Michael Knauth; Ralf W Baumgartner
Journal:  High Alt Med Biol       Date:  2004       Impact factor: 1.981

5.  Association of eNOS Glu298Asp gene polymorphism with essential hypertension in Asian Indians.

Authors:  Kamna Srivastava; Rajiv Narang; V Sreenivas; Sabri Das; Nibhriti Das
Journal:  Clin Chim Acta       Date:  2007-09-19       Impact factor: 3.786

6.  Genetic Data Analysis. Methods for Discrete Population Genetic Data. Bruce S. Weir. Sinauer, Sunderland, MA, 1990. xiv, 377 pp., illus. $48; paper, $27.

Authors:  R R Hudson
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

7.  Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.

Authors:  Xinxin Yu; Shawn C Burgess; Hongfei Ge; Kenny K Wong; R Haris Nassem; Daniel J Garry; A Dean Sherry; Craig R Malloy; Joel P Berger; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

8.  Genotype at the missense G894T polymorphism (Glu298Asp) in the NOS3 gene is associated with susceptibility to acute mountain sickness.

Authors:  Pei Wang; Michael S Koehle; Jim L Rupert
Journal:  High Alt Med Biol       Date:  2009       Impact factor: 1.981

Review 9.  Genetics in geographically structured populations: defining, estimating and interpreting F(ST).

Authors:  Kent E Holsinger; Bruce S Weir
Journal:  Nat Rev Genet       Date:  2009-09       Impact factor: 53.242

Review 10.  The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease.

Authors:  David I R Holmes; Ian Zachary
Journal:  Genome Biol       Date:  2005-02-01       Impact factor: 13.583

View more
  18 in total

1.  The Local HIF-2α/EPO Pathway in the Bone Marrow is Associated with Excessive Erythrocytosis and the Increase in Bone Marrow Microvessel Density in Chronic Mountain Sickness.

Authors:  Juan Su; Zhanquan Li; Sen Cui; Linhua Ji; Hui Geng; Kexia Chai; Xiaojing Ma; Zhenzhong Bai; Yingzhong Yang; Tana Wuren; Ri-Li Ge; Matthew T Rondina
Journal:  High Alt Med Biol       Date:  2015-12-01       Impact factor: 1.981

2.  Genetic variants of endothelial PAS domain protein 1 are associated with susceptibility to acute mountain sickness in individuals unaccustomed to high altitude: A nested case-control study.

Authors:  L I Guo; Jihang Zhang; Jun Jin; Xubin Gao; Jie Yu; Qianwen Geng; Huijie Li; Lan Huang
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

3.  Altered iPSC-derived neurons' sodium channel properties in subjects with Monge's disease.

Authors:  H W Zhao; X Q Gu; T Chailangkarn; G Perkins; D Callacondo; O Appenzeller; O Poulsen; D Zhou; A R Muotri; G G Haddad
Journal:  Neuroscience       Date:  2015-01-03       Impact factor: 3.590

Review 4.  Regulatory SNPs and transcriptional factor binding sites in ADRBK1, AKT3, ATF3, DIO2, TBXA2R and VEGFA.

Authors:  Norman E Buroker
Journal:  Transcription       Date:  2014-10-31

5.  VEGFA rSNPs, transcriptional factor binding sites and human disease.

Authors:  Norman E Buroker
Journal:  J Physiol Sci       Date:  2013-10-06       Impact factor: 2.781

6.  VEGFA SNPs and transcriptional factor binding sites associated with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.

Authors:  Norman E Buroker; Xue-Han Ning; Zhao-Nian Zhou; Kui Li; Wei-Jun Cen; Xiu-Feng Wu; Wei-Zhong Zhu; C Ronald Scott; Shi-Han Chen
Journal:  J Physiol Sci       Date:  2013-04-04       Impact factor: 2.781

7.  Vascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean population.

Authors:  Jose R Espinoza; Giancarlo Alvarez; Fabiola León-Velarde; Hugo F Ju Preciado; Jose-Luis Macarlupu; Maria Rivera-Ch; Jorge Rodriguez; Judith Favier; Anne-Paule Gimenez-Roqueplo; Jean-Paul Richalet
Journal:  High Alt Med Biol       Date:  2014-06       Impact factor: 1.981

8.  CardioGxE, a catalog of gene-environment interactions for cardiometabolic traits.

Authors:  Laurence D Parnell; Britt A Blokker; Hassan S Dashti; Paula-Dene Nesbeth; Brittany Elle Cooper; Yiyi Ma; Yu-Chi Lee; Ruixue Hou; Chao-Qiang Lai; Kris Richardson; José M Ordovás
Journal:  BioData Min       Date:  2014-10-26       Impact factor: 2.522

9.  Single Nucleotide Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome.

Authors:  Maija Suvanto; Timo Jahnukainen; Marjo Kestilä; Hannu Jalanko
Journal:  Int J Nephrol       Date:  2016-05-09

10.  Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.

Authors:  Merry-Lynn N McDonald; Michael H Cho; Inga-Cecilie Sørheim; Sharon M Lutz; Peter J Castaldi; David A Lomas; Harvey O Coxson; Lisa D Edwards; William MacNee; Jørgen Vestbo; Julie C Yates; Alvar Agusti; Peter M A Calverley; Bartolome Celli; Courtney Crim; Stephen I Rennard; Emiel F M Wouters; Per Bakke; Ruth Tal-Singer; Bruce E Miller; Amund Gulsvik; Richard Casaburi; J Michael Wells; Elizabeth A Regan; Barry J Make; John E Hokanson; Christoph Lange; James D Crapo; Terri H Beaty; Edwin K Silverman; Craig P Hersh
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.